Evidence-based hormone health
TRT benefits and risks, weighed honestly
Real benefits for men with deficiency, real risks to manage, and a few claims the evidence doesn’t support.
AR
Medically reviewed by Alan Reyes, MD, FACEBoard-certified endocrinologist · 18 years in hormone healthLast reviewed Sep 1, 2026 · AI-assisted draft, physician-verified
What the evidence supports
| Outcome | What research shows | Evidence |
|---|---|---|
| Libido & sexual function | Consistent improvement in men with low T; among the most reliable benefits. Effects begin within 3–6 weeks.1,2 | Strong |
| Mood & depressive symptoms | Modest improvement in some men with low T; not a treatment for clinical depression on its own.3 | Moderate |
| Lean mass & strength | Increases muscle mass and reduces fat mass over 3–12 months, especially combined with resistance training.4 | Strong |
| Bone density | Improves bone mineral density; fracture-reduction data are less clear.1 | Moderate |
| Energy & fatigue | Improvement in some men with deficiency; results are variable and overlap with placebo.3 | Moderate |
| Cognition / “brain fog” | No consistent benefit demonstrated in trials to date.3 | Weak |
The risks and how they’re managed
| Risk | What to know |
|---|---|
| Fertility suppression | TRT signals the brain to stop stimulating the testes, reducing sperm production — sometimes to zero. Often reversible after stopping, but not always. Critical if you may want children. Full guide →5 |
| Elevated hematocrit | Testosterone raises red-blood-cell count; too high thickens blood and raises clot risk. Monitored with regular CBCs; managed by dose reduction or blood donation.1 |
| Cardiovascular | The TRAVERSE trial (2023, NEJM) found testosterone non-inferior to placebo for major cardiac events in men with low T and high CV risk — reassuring, though a modest increase in atrial fibrillation and pulmonary embolism was seen. Deep dive →6 |
| Prostate | TRT does not appear to cause prostate cancer, but can accelerate an existing one. PSA and exams are monitored; active prostate cancer is a contraindication.1 |
| Estrogen-related | Some testosterone converts to estradiol; excess can cause breast tenderness or fluid retention. Monitored and managed clinically.1 |
| Skin & other | Acne, oily skin, sleep-apnea worsening, and injection-site or application reactions depending on method.1 |
Claims the evidence does not support: that TRT reliably reverses aging, dramatically boosts cognition, or benefits men with normal testosterone. Marketing that promises these is ahead of the science.
The bottom line
For men with genuine, symptomatic deficiency, the benefit-to-risk balance is often favorable with proper monitoring. For men with normal levels, the risks are real and the benefits largely absent. That’s why diagnosis — not marketing — should drive the decision.
This is not medical advice. Your individual risk depends on age, health history, and labs. Discuss benefits and risks with a licensed physician who can monitor you over time.
References
- Snyder PJ, et al. Effects of Testosterone Treatment in Older Men (Testosterone Trials), NEJM. nejm.org. 2016.
- Saad F, et al. Onset and time course of the effects of testosterone treatment. pubmed.ncbi.nlm.nih.gov. 2011.
- Bhasin S, et al. Endocrine Society Clinical Practice Guideline. academic.oup.com. 2018.
- Bhasin S, et al. Testosterone dose-response relationships in healthy young men. pubmed.ncbi.nlm.nih.gov. 2001.
- Patel AS, et al. Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility. pubmed.ncbi.nlm.nih.gov. 2019.
- Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE), NEJM. nejm.org. 2023.